Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.82M | 2.98M | 2.99M | 2.92M | 3.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.82M | 2.98M | 2.99M | 2.92M | 3.03M |
| Cost of Revenue | 2.37M | 2.12M | 2.31M | 2.20M | 2.39M |
| Gross Profit | 449.00K | 856.00K | 676.00K | 723.00K | 633.00K |
| SG&A Expenses | 4.61M | 5.64M | 5.38M | 5.71M | 5.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.75M | 11.59M | 11.59M | 13.08M | 13.76M |
| Operating Income | -7.93M | -8.62M | -8.61M | -10.16M | -10.73M |
| Income Before Tax | -9.66M | -14.64M | -11.59M | -14.23M | -12.43M |
| Income Tax Expenses | -66.00K | -- | -- | -- | 564.00K |
| Earnings from Continuing Operations | -9.59M | -14.64M | -11.59M | -14.23M | -13.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.59M | -14.64M | -11.59M | -14.23M | -13.00M |
| EBIT | -7.93M | -8.62M | -8.61M | -10.16M | -10.73M |
| EBITDA | -7.12M | -7.74M | -7.73M | -9.30M | -9.91M |
| EPS Basic | -0.38 | -0.59 | -0.50 | -0.74 | -0.89 |
| Normalized Basic EPS | -0.37 | -0.29 | -0.33 | -0.46 | 0.02 |
| EPS Diluted | -0.38 | -0.59 | -0.50 | -0.74 | -0.89 |
| Normalized Diluted EPS | -0.37 | -0.29 | -0.33 | -0.46 | 0.02 |
| Average Basic Shares Outstanding | 25.21M | 24.92M | 23.06M | 19.22M | 14.58M |
| Average Diluted Shares Outstanding | 25.21M | 24.92M | 23.06M | 19.22M | 14.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
